A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation
…, O Nemirovskiy, S Ogawa, L Pegg, M Pelc… - … of Pharmacology and …, 2010 - ASPET
Autotaxin is the enzyme responsible for the production of lysophosphatidic acid (LPA) from
lysophosphatidyl choline (LPC), and it is up-regulated in many inflammatory conditions, …
lysophosphatidyl choline (LPC), and it is up-regulated in many inflammatory conditions, …
Getting to the bottom of a granular medium
MB Stone, DP Bernstein, R Barry, MD Pelc, YK Tsui… - Nature, 2004 - nature.com
Penetration by an object through a dense granular medium (for example, by a finger pushing
slowly into the sand on a beach) presents an interesting physics problem 1 that is closely …
slowly into the sand on a beach) presents an interesting physics problem 1 that is closely …
Development of the enabling route for glecaprevir via ring-closing metathesis
…, KA Lukin, RD Bishop, G Zhao, MJ Pelc… - … Process Research & …, 2019 - ACS Publications
Glecaprevir was identified as a potent HCV NS3/4A protease inhibitor, and an enabling
synthesis was required to support the preclinical evaluation and subsequent Phase I clinical trials…
synthesis was required to support the preclinical evaluation and subsequent Phase I clinical trials…
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally …
…, D Noteberg, P Nuhant, MJ Pelc… - Journal of Medicinal …, 2018 - ACS Publications
The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also
known as RORγt) is a promising target for the treatment of autoimmune diseases. A small …
known as RORγt) is a promising target for the treatment of autoimmune diseases. A small …
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
The work described herein demonstrates the utility of structure-based drug design (SBDD) in
shifting the binding mode of an HTS hit from a DFG-in to a DFG-out binding mode resulting …
shifting the binding mode of an HTS hit from a DFG-in to a DFG-out binding mode resulting …
An approach to the imine ring system of pinnatoxins
MJ Pelc, A Zakarian - Organic Letters, 2005 - ACS Publications
A concise stereoselective approach to the spirobicyclic imine fragment of pinnatoxins and
pteriatoxins is described. The approach relies on a tandem reaction sequence involving …
pteriatoxins is described. The approach relies on a tandem reaction sequence involving …
Development of a large-scale route to glecaprevir: synthesis of the side chain and final assembly
…, RE Reddy, AB Kielbus, MJ Pelc… - … Process Research & …, 2020 - ACS Publications
The preceding article described the development of the large-scale synthetic route to
macrocycle 3 of glecaprevir (1), a potent HCV protease inhibitor. This article describes the …
macrocycle 3 of glecaprevir (1), a potent HCV protease inhibitor. This article describes the …
Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro [3.5] nonane urea PF-04862853, an orally efficacious …
MJ Meyers, SA Long, MJ Pelc, JL Wang… - Bioorganic & medicinal …, 2011 - Elsevier
Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase responsible
for the degradation of fatty acid amide signaling molecules such as endocannabinoid …
for the degradation of fatty acid amide signaling molecules such as endocannabinoid …
Discovery of an oral potent selective inhibitor of hematopoietic prostaglandin D synthase (HPGDS)
…, BC Hamper, T Dice, BE Neal, MJ Pelc… - ACS medicinal …, 2010 - ACS Publications
Hematopoietic prostaglandin D synthase (HPGDS) is primarly expressed in mast cells,
antigen-presenting cells, and Th-2 cells. HPGDS converts PGH 2 into PGD 2 , a mediator thought …
antigen-presenting cells, and Th-2 cells. HPGDS converts PGH 2 into PGD 2 , a mediator thought …
Development of a Large-Scale Route to Glecaprevir: Synthesis of the Macrocycle via Intramolecular Etherification
JM Kallemeyn, KM Engstrom, MJ Pelc… - … Process Research & …, 2020 - ACS Publications
Glecaprevir was identified as a potent hepatitis C virus (HCV) protease inhibitor, and a large-scale
synthesis was required to support the late-stage clinical trials and subsequent …
synthesis was required to support the late-stage clinical trials and subsequent …